{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:33Z","timestamp":1792740513459,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>3M syndrome (3MS) is a very rare autosomal recessive disorder characterized by short stature, distinctive facial features, and skeletal abnormalities. The condition is frequently underdiagnosed due to its nonspecific symptoms and normal neurocognitive development. Few reports exist on its clinical course and response to growth hormone (GH) therapy. Therefore, this study aims to describe the clinical features of Saudi patients with 3MS and to investigate the effects of growth hormone therapy on growth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective case series of 14 Saudi patients from 11 families with genetically confirmed 3MS at King Faisal Specialist Hospital and Research Centre in Riyadh.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age at diagnosis was 5.4 years. Consanguinity was present in 79% of cases. The most frequently affected gene was\n                      <jats:italic>CUL7<\/jats:italic>\n                      (57% of cases), followed by\n                      <jats:italic>OBSL1<\/jats:italic>\n                      and\n                      <jats:italic>CCDC8<\/jats:italic>\n                      . All variants were predominantly homozygous and classified as pathogenic or likely pathogenic. Clinical abnormalities included growth retardation, dental abnormalities, spinal abnormalities, and a characteristic facial appearance. GH therapy was administered to 10 children; 5 demonstrated a measurable improvement in growth velocity, while 5 did not respond or discontinued treatment. IGF-1 was within\/low-normal in most tested cases, with two elevated results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study highlights the extensive phenotypic variability of 3MS and underscores the predominantly autosomal recessive inheritance pattern in this population. GH therapy may provide a growth benefit in select cases, although resistance and poor response remain a challenge. Genetic testing is crucial for accurate diagnosis, individualized management, and appropriate family counseling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1666468","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:10:38Z","timestamp":1762837838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["3M syndrome in Saudi Arabia: a case series study and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Raghad","family":"Alhuthil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afaf","family":"Alsagheir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Almslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Raed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassam","family":"Bin-Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-39-21","article-title":"3-M syndrome associated with growth hormone deficiency: 18-year follow-up of a patient","volume":"39","author":"Meazza","year":"2013","journal-title":"Ital J Pediatr"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04428.x","article-title":"Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination","volume":"77","author":"Clayton","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61989","article-title":"A rare cause of syndromic short stature: 3M syndrome in three families","volume":"185","author":"Isik","year":"2021","journal-title":"Am J Med Genet A"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.21.2.124","article-title":"The 3-M syndrome","volume":"21","author":"Winter","year":"1984","journal-title":"J Med Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.v3i3.30","article-title":"3-M syndrome: A report of four cases in two families","volume":"3","author":"Guven","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B6","first-page":"39","article-title":"The 3-M syndrome: A heritable low birthweight dwarfism","volume":"11","author":"Miller","year":"1975","journal-title":"Birth Defects Orig Artic Ser"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ng1628","article-title":"Identification of mutations in CUL7 in 3-M syndrome","volume":"37","author":"Huber","year":"2005","journal-title":"Nat Genet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ejhg.2008.200","article-title":"A large-scale mutation search reveals genetic heterogeneity in 3M syndrome","volume":"17","author":"Huber","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1530\/JME-12-0034","article-title":"Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling","volume":"49","author":"Hanson","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12041-019-1057-6","article-title":"Novel mutation in Cul7 gene in a family diagnosed with 3M syndrome","volume":"98","author":"Shaikh","year":"2019","journal-title":"J Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.18549\/PharmPract.2024.1.2908","article-title":"The first study of 3-M syndrome in Jordan and Literature Review","volume":"22","author":"Alkhawaldeh","year":"2024","journal-title":"Pharm Pract (Granada)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00431-024-05855-2","article-title":"Clinical and molecular spectrum along with genotype\u2013phenotype correlation of 25 patients diagnosed with 3M syndrome: a study from Turkey","volume":"184","author":"Akal\u0131n","year":"2025","journal-title":"Eur J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e64068","DOI":"10.1002\/ajmg.a.64068","article-title":"An update on 3M syndrome: review of clinical and molecular aspects and report of additional families","volume":"197","author":"Elsayed","year":"2025","journal-title":"Am J Med Genet Part A"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1211254","article-title":"Case report: Artemis deficiency and 3M syndrome\u2014coexistence of two distinct genetic disorders","volume":"11","author":"Ceylan","year":"2023","journal-title":"Front Pediatr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2020-0278","article-title":"Effect of recombinant human insulin-like growth factor 1 therapy in a child with 3-M syndrome-1 with CUL7 gene mutation","volume":"33","author":"Yang","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ejhg.2011.32","article-title":"Clinical utility gene card for: 3M syndrome","volume":"19","author":"Holder-Espinasse","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2016.01.009","article-title":"Pre-and post-natal growth in two sisters with 3-M syndrome","volume":"59","author":"Lugli","year":"2016","journal-title":"Eur J Med Genet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104346","article-title":"Natural history of facial and skeletal features from neonatal period to adulthood in a 3M syndrome cohort with biallelic CUL7 or OBSL1 variants","volume":"64","author":"T\u00fcys\u00fcz","year":"2021","journal-title":"Eur J Med Genet"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1530\/endoabs.110.EP733","article-title":"Treatment responce of the growth hormone in 3M syndrome: a single center experience","volume-title":"Endocrine abstracts","author":"Altun","year":"2025"},{"key":"B20","article-title":"Three M syndrome","volume-title":"GeneReviews\u00ae","author":"Akilapa","year":"2002"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2284","DOI":"10.1002\/mgg3.2284","article-title":"Prenatal diagnosis and preimplantation genetics testing of 3M syndrome in a Chinese family with novel biallelic variants of CUL7","volume":"12","author":"Wang","year":"2024","journal-title":"Mol Genet Genomic Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"501","DOI":"10.4274\/jcrpe.galenos.2024.2023-11-6","article-title":"Novel OBSL1 variant in a Chinese patient with 3M syndrome: The c. 458dupG mutation may be a potential hotspot mutation in the Chinese population","volume":"16","author":"Piao","year":"2024","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i8.1454","article-title":"3M syndrome patient with a novel mutation: A case report","volume":"12","author":"Luo","year":"2024","journal-title":"World J Clin cases"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.53853\/encr.11.3.900","article-title":"S\u00edndrome 3-M (Miller, McKusick, Malvaux): otra causa de talla baja gen\u00e9tica","volume":"11","author":"Gomez","year":"2024","journal-title":"Rev Colomb Endocrinol Diabetes Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1164936","article-title":"Chinese patients with 3M syndrome: clinical manifestations and two novel pathogenic variants","volume":"14","author":"Xu","year":"2023","journal-title":"Front Genet"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2023.104828","article-title":"3M syndrome: Evaluating the clinical and laboratory features and the response of the growth hormone treatment: Single center experience","volume":"66","author":"K\u00fc\u00e7\u00fckali","year":"2023","journal-title":"Eur J Med Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000524703","article-title":"Typical face, developmental delay, and hearing loss in a patient with 3M syndrome: the co-occurrence of two rare conditions","volume":"13","author":"Akal\u0131n","year":"2022","journal-title":"Mol Syndromol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104448","article-title":"3M syndrome: A Tunisian seven-cases series","volume":"65","author":"Khachnaoui-Zaafrane","year":"2022","journal-title":"Eur J Med Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2020.61.11.981","article-title":"The effect of combined growth hormone and a gonadotropin-release hormone agonist therapy on height in korean 3-M syndrome siblings","volume":"61","author":"Lee","year":"2020","journal-title":"Yonsei Med J"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61154","article-title":"Further expanding the mutational spectrum and investigation of genotype\u2013phenotype correlation in 3M syndrome","volume":"179","author":"Simsek-Kiper","year":"2019","journal-title":"Am J Med Genet A"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.912736","article-title":"3-M syndrome: A local case report","volume":"20","author":"HabibUllah","year":"2019","journal-title":"Am J Case Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1164936","article-title":"Chinese patients with 3M syndrome: clinical manifestations and two novel pathogenic variants","volume":"14","author":"Xu","year":"2023","journal-title":"Front Genet"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1666468\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:10:42Z","timestamp":1762837842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1666468\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":32,"alternative-id":["10.3389\/fendo.2025.1666468"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1666468","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"article-number":"1666468"}}